Abbott Laboratories

ABT

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0000001800

SEC filings (opens in a new tab)

In the last 90 days, Abbott Laboratories insiders filed 0 open-market purchases and 4 sales; 3,001 institutions reported holding it in 13F filings for Q2 2026, worth $125.2B in total; 3 superinvestors hold it, including Southeastern Asset Management (Longleaf) and Soros Fund Management.

Key figures

Market capClose on Nov 10, 2026: $191.3B
Insider buysOpen market, last 90 days: 0
Insider sellsLast 90 days, $47.3M in total: 4
13F holdersQ2 2026, −87 vs. previous quarter: 3,001
13F valueReported value at the end of Q2 2026: $125.2B
Superinvestors holdingAt the end of Q2 2026: 3

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: $44.3B; +5.7% year over year
Net income, FY2025: $6.52B; −51.3% year over year
Free cash flow, FY2025: $7.39B; +16.4% year over year
Revenue, Q3 FY2026: $13.0B; +14.5% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 19.1M; Shares sold short
Change: +1.67M; +9.6% vs. previous
Days to cover: 1.91; At average daily volume

Superinvestors holding ABT, Q2 2026

Go to the superinvestors tab

3 superinvestors report holding Abbott Laboratories on Form 13F. Percentages are the stock's share of each portfolio.

Southeastern Asset Management (Longleaf)

Mason Hawkins

4.0%

Abbott Laboratories's share of the portfolio

Shares: 840,747
Value: $76.3M

Soros Fund Management

George Soros

0.1%

Abbott Laboratories's share of the portfolio

Shares: 44,750
Value: $4.06M

Other superinvestors holding ABT (part 1)
Superinvestor	Weight	Value
Gardner Russo & Quinn	<0.1%	$1.04M

Latest insider trades

See all insider trades

Open-market purchases and sales by Abbott Laboratories insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 6, 2026 (view filing)5:09 PM ET	Nov 5	1 day	Moreland Mary KEXECUTIVE VICE PRESIDENT	SSaleCommon shares without par value	−3.50K	$116.00	−$406.0K	−3.4%100.8K after
Sep 3, 2026 (view filing)6:11 PM ET	Sep 2	1 day	McCoy John A. Jr.VICE PRESIDENT AND CONTROLLER	SSaleCommon shares without par value	−27	$109.54	−$2.96K	−0.1%24.5K after
Aug 27, 2026 (view filing)5:09 PM ET	Aug 25	2 days	Ford Robert BCHAIRMAN AND CEO	SSaleCommon shares without par value	−398.8K	$115.85	−$46.2M	−56.5%306.5K after	2 lots
Aug 13, 2026 (view filing)5:14 PM ET	Aug 11	2 days	Morrone Louis H.EXECUTIVE VICE PRESIDENT	SSaleCommon shares without par value	−5.85K	$109.83	−$642.5K	−7.6%70.7K after
Jun 18, 2026 (view filing)	May 7	42 daysLate	Stratton John GDirector	PPurchaseCommon shares without par value	+2.00K	$86.82	+$173.6K	+9.4%23.3K after
Apr 28, 2026 (view filing)	Apr 27	1 day	Starks Daniel JDirector	PPurchaseCommon shares without par value	+10.0K	$92.65	+$926.5K	+0.1%6.75M after
Apr 27, 2026 (view filing)	Apr 23	4 days	Boudreau Philip PEVP AND CFO	PPurchaseCommon shares without par value	+2.20K	$91.50	+$201.3K	New position2.20K after
Mar 3, 2026 (view filing)	Mar 2	1 day	Cushman Elizabeth C.EVP, GC AND SECRETARY	SSaleCommon shares without par value	−263	$115.58	−$30.4K	−0.7%38.6K after
Mar 3, 2026 (view filing)	Mar 2	1 day	Shroff EricSenior Vice President	SSaleCommon shares without par value	−709	$115.58	−$81.9K	−1.8%39.2K after
Mar 3, 2026 (view filing)	Mar 2	1 day	Morrone Louis H.EXECUTIVE VICE PRESIDENT	SSaleCommon shares without par value	−1.14K	$115.58	−$132.2K	−1.5%76.8K after

Top 10 13F holders, Q2 2026

See all 3,001 holders

The largest institutional positions in Abbott Laboratories at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding ABT in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
BlackRock, Inc.	152,563,476	$13.8B	0.21%	+6,876,018+4.7%	Added
Vanguard Capital Management LLC	113,750,994	$10.3B	0.22%	+801,061+0.7%	Added
State Street Corp	80,926,234	$7.34B	0.22%	+1,350,766+1.7%	Added
Charles Schwab Investment Management Inc	59,674,507	$5.41B	0.72%	+14,174,452+31.2%	Added
Vanguard Portfolio Management LLC	49,017,866	$4.45B	0.20%	+1,072,975+2.2%	Added
Geode Capital Management, LLC	39,219,337	$3.54B	0.19%	+70,542+0.2%	Added
Capital Research Global Investors	36,908,990	$3.35B	0.47%	−12,866,372−25.8%	Reduced
Capital International Investors	34,654,113	$3.15B	0.65%	−2,844,114−7.6%	Reduced
Morgan Stanley	26,611,315	$2.41B	0.13%	−3,490,281−11.6%	Reduced
Norges Bank	23,354,911	$2.12B	0.21%	+23,354,911	New

Holders of 5% or more of ABT

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Abbott Laboratories.

Largest holders of ABT from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Vanguard Capital Management LLC	13G	7.50%130.7M shares	New	Apr 29, 20261 filing	Apr 29, 2026	SEC

Politician trades

All politician trades in ABT

39 members of Congress reported 113 trades in Abbott Laboratories since 2020. Newest filings:

Latest politician trades in ABT
Filed	Politician	Type	Amount
Oct 30, 2026	Thomas H. Kean, Jr. House · NJ	Sell (partial)	$1K-$15K
Oct 27, 2026	Pete Sessions House · TX	Sell	$50K-$100K
Oct 12, 2026	Gilbert Ray Cisneros, Jr. House · CA	Buy	$1K-$15K
Aug 18, 2026	Rick W. Allen House · GA	Sell	$15K-$50K
Aug 14, 2026	Richard McCormick House · GA	Sell	$1K-$15K

Thomas H. Kean, Jr.
House · NJ · Oct 30, 2026
Sell (partial)$1K-$15K
Pete Sessions
House · TX · Oct 27, 2026
Sell$50K-$100K
Gilbert Ray Cisneros, Jr.
House · CA · Oct 12, 2026
Buy$1K-$15K
Rick W. Allen
House · GA · Aug 18, 2026
Sell$15K-$50K
Richard McCormick
House · GA · Aug 14, 2026
Sell$1K-$15K